AFL vs EBS
Aflac Incorporated (AFL) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Aflac Incorporated (AFL) is a insurance - life company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AFL revenue for 2024-12-31 was $18.93B. Net income was $5.44B. Revenue was up 401.1% from 2023-12-31 to 2024-12-31. AFL currently screens at market cap $60.18B and trailing P/E 13.5.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
AFL currently screens at market cap $60.18B and trailing P/E 13.5. EBS currently screens at market cap $416.4M.
Not investment advice. Open the AFL and EBS stock pages for the full models.
Not investment advice.